Effectiveness of sequential use of biologics in the treatment of moderate to severe psoriasis in real world Canadian academic clinical practice: A cohort study

被引：5
|
作者：
Qiang, Judy K. [1 ]
Shahbaz, Ali [2 ]
Kim, Whan [3 ]
Marinas, Joseph [3 ]
Greaves, Simon [4 ]
Yeung, Jensen [5 ]
机构：
[1] Univ Toronto, Fac Med, Toronto, ON M5S 1B2, Canada
[2] Univ Ottawa, Sch Med, Ottawa, ON K1N 6N5, Canada
[3] McMaster Univ, Michael G DeGroote Sch Med, Hamilton, ON, Canada
[4] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON M5S 1B2, Canada
[5] Univ Toronto, Div Dermatol, Dept Med, Toronto, ON M5S 1B2, Canada
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2016年 / 74卷 / 01期
关键词：
TO-SEVERE PSORIASIS; ETANERCEPT; EFFICACY;
D O I：
10.1016/j.jaad.2015.08.030
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
[No abstract available]
引用
收藏
页码：176 / 177
页数：3
相关论文
共 50 条
  • [1] Sequential use of biologics in the treatment of moderate-to-severe plaque psoriasis
    Leman, J.
    Burden, A. D.
    BRITISH JOURNAL OF DERMATOLOGY, 2012, 167 : 12 - 20
  • [2] Effectiveness and safety of deucravacitinib treatment for moderate-to-severe psoriasis in real-world clinical practice in Japan
    Hagino, Teppei
    Saeki, Hidehisa
    Fujimoto, Eita
    Kanda, Naoko
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2024, 35 (01)
  • [3] Use of Biologics in the Treatment of Moderate-to-Severe Plantar Psoriasis
    Ekladios, Josh
    Jolliffe, Jason
    Panchigar, Shalin
    Qureshi, Rafay
    Shete, Ankita
    Wellner, Jason
    Vlahovic, Tracey C.
    CLINICS IN PODIATRIC MEDICINE AND SURGERY, 2021, 38 (04) : 553 - 559
  • [4] Effectiveness in real world practice after 4 weeks of Risankizumab treatment for patients with moderate-to-severe psoriasis: 15patient cohort
    Navarro-Guillamon, Pedro J.
    Carmona-Olveira, Ana
    Herrera-Acosta, Enrique
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (03) : AB49 - AB49
  • [5] Ixekizumab for treatment of moderate to severe plaque psoriasis: real world clinical experience
    Diotallevi, Federico
    Campanati, Anna
    Radi, Giulia
    Molinelli, Elisa
    Offidani, Annamaria
    GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA, 2020, 155 (06): : 739 - 743
  • [6] Comparison of the disease survival of biologics for the treatment of moderate-to-severe psoriasis: real-world data
    Oh, S-M
    Kang, K-W
    Kang, D-H
    Kwon, S-H
    Lew, B-L
    Shin, M. K.
    Jeong, K-H
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2023, 143 (11) : S343 - S343
  • [7] Effectiveness and safety of secukinumab in Chinese patients with moderate to severe plaque psoriasis in real-world practice
    Zhou, Jian
    Yuan, Yuan
    Liu, Yanhua
    Chu, Mengyang
    Liu, Huan
    Liu, Qian
    Wang, Rui
    Shao, Shuai
    Wang, Gang
    Yu, Chen
    EXPERIMENTAL DERMATOLOGY, 2024, 33 (01)
  • [8] Real-world, long-term treatment patterns of commonly used biologics in Canadian patients with moderate-to-severe chronic plaque psoriasis
    Gooderham, Melinda J.
    Lynde, Charles
    Turchin, Irina
    Avadisian, Miriam
    Labelle, Melanie
    Papp, Kim A.
    JOURNAL OF DERMATOLOGY, 2022, 49 (01): : 95 - 105
  • [9] Certolizumab Pegol Use in the Treatment of Moderate-to-Severe Psoriasis: Real-World Data From Two Canadian Centers
    Vender, Ronald B.
    Lynde, Charles W.
    JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, 2022, 26 (03) : 267 - 273
  • [10] The use of biologic therapies for the treatment of moderate-to-severe psoriasis in UK clinical practice
    Warren, R.
    Brown, B.
    Lavery, D.
    Ashcroft, D.
    Griffiths, C.
    BRITISH JOURNAL OF DERMATOLOGY, 2008, 159 (06) : 1411 - 1412
12345